This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
About
Professor Peter van Wijngaarden
Honorary
Professor Peter van Wijngaarden is an ophthalmologist and medical scientist with research interests in diabetic retinopathy, Alzheimer’s disease and retinal imaging biomarker discovery. He has research experience in retinal vascular biology and central nervous system regeneration.
Professor Peter van Wijngaarden
Honorary
MBBS(Hons), PhD, FRANZCO
Professor Peter van Wijngaarden is Managing Director of The Florey and Professor of Ophthalmology at the University of Melbourne.
He is a current honorary researcher and former deputy director of the Centre for Eye Research Australia.
He is a founding steering committee member and clinical director of KeepSight – a national program for diabetic retinopathy screening that seeks to reach every Australian with diabetes to prevent avoidable blindness.
Prof van Wijngaarden is a member of the Research and Medical Committees of the Macular Disease Foundation of Australia.
He is a member of the Australian Alliance for Artificial Intelligence in Healthcare Workforce Program Committee and the Futures of Ophthalmology Taskforce of the Royal Australian and New Zealand College of Ophthalmologists.
Key research questions
- Can hyperspectral retinal imaging be used to detect people who are at risk of Alzheimer’s disease before the onset of dementia?
- What are the earliest features of Alzheimer’s disease that can be detected with retinal imaging and how long before the onset of dementia are they apparent?
- Can hyperspectral retinal imaging be used to monitor disease progression and treatment responses in Alzheimer’s disease?
- Can hyperspectral retinal imaging be used to identify novel features of eye and brain diseases, including predictors of progression?
Current projects
Selected publications
Key collaborators
Funding and support
Current projects
Retinal imaging in Alzheimer’s disease
- Diagnostic support
- Screening
- Disease and treatment monitoring
Retinal imaging in eye diseases
- Diabetic retinopathy & retinal vascular diseases
- Age-related macular degeneration
- Glaucoma
- Inherited retinal diseases
Selected publications
Xavier Hadoux, Flora Hui, Colin Masters, Alice Pébay, Sophie Chevalier, Jason Ha, Samantha Loi, Christopher J. Fowler, Christopher Rowe, Victor L.Villemagne, Edward N. Taylor, Christopher Fluke, Jean-Paul Soucy, Frédéric Lesage, Jean-Philippe Sylvestre, Pedro Rosa-Neto, Sulantha Mathotaarachchi,Serge Gauthier, Ziad S. Nasreddine, Jean Daniel Arbour, Marc-André Rhéaume, Sylvain Beaulieu, Mohamed Dirani, Robert Williamson, Jonathan G. Crowston, Peter van Wijngaarden*. Non-invasive, in vivo Hyperspectral Imaging identifies a Retinal Biomarker for Alzheimer’s Disease. Nature Communications. 2019, 17 September, 10:4227. DOI: 10.1038/s41467-019-12242-1.
Björn Neumann, Roey Baror, Chao Zhao, Michael Segel, Sabine Dietmann, Khalil S. Rawji, Sarah Foerster, Crystal R. McClain, Kevin Chalut, Peter van Wijngaarden* and Robin J.M. Franklin*. Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells. Cell Stem Cell. 2019 Oct 3;25(4):473-485.e8. DOI: 10.1016/j.stem.2019.08.015
Peter van Wijngaarden, Xavier Hadoux, Mostafa Alwan, Stuart Keel, Mohamed Dirani, M. Emerging ocular biomarkers of Alzheimer’s disease. Clinical Experimental Ophthalmology. 2017 Jan;45(1):54-61. DOI: 10.1111/ceo.12872
Veronique E. Miron, Amanda Boyd, Jing-Wei Zhao, Tracy J. Yuen, Julia M. Ruckh, Peter van Wijngaarden, Jennifer L. Shadrach, Amy J. Wagers, Anna Williams, Robin J.M. Franklin, Charles French-Constant. M1 to M2 polarization switch in microglia/ macrophages drives oligodendrocyte differentiation during CNS remyelination. Nature Neuroscience. 2013; 16:1211-8. DOI: 10.1038/nn.3469
Peter van Wijngaarden and Robin J.M. Franklin. Ageing stem and progenitor cells: implications for rejuvenation of the central nervous system. Development. 2013; 140:2562-75. (IF: 5.76; #4/43; Q1). DOI: 10.1242/dev.092262
Julia M. Ruckh, Jing-Wei Zhao, Jennifer L. Shadrach JL, Peter van Wijngaarden, Tata Nageswara Rao, Amy J. Wagers, Robin J. M. Franklin. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell. 2012; 10:96-103. doi: 10.1016/j.stem.2011.11.019
See more publications
Key collaborators
- Dr Xavier Hadoux – Senior Post-doctoral research fellow
- Dr Zhichao Wu – Head of Clinical Biomarkers Research, CERA
- A/Professors Yen Ying Lim, Matthew Pase and Nawaf Yassi – The Healthy Brain Project, Melbourne.
- Dr Christopher Fowler, Professor Colin Masters and the Australian Imaging, Biomarkers and Lifestyle Study of Ageing, Melbourne.
- Professors Ingeborg Stalmaans, Lieve Moons and Dr Lies De Groef, KU Leuven, Belgium.
Funding and support
Thank you to the following organisations for their support:
- Yulgilbar Alzheimer’s Research Program
- H&L Hecht Trust
- Alzheimer’s Drug Discovery Foundation Diagnostics Accelerator
- National Foundation of Medical Research and Innovation
- Lord Mayor’s Charitable Foundation Eldon and Anne Foote Donor Advised Grant
Contact Professor Peter van Wijngaarden
Leave a direct enquiry for CERA below!
Please note: Unfortunately we are not able to provide individual medical advice over email.
